ATE133200T1 - Modifiziertes, biologisch aktives protein - Google Patents

Modifiziertes, biologisch aktives protein

Info

Publication number
ATE133200T1
ATE133200T1 AT90112690T AT90112690T ATE133200T1 AT E133200 T1 ATE133200 T1 AT E133200T1 AT 90112690 T AT90112690 T AT 90112690T AT 90112690 T AT90112690 T AT 90112690T AT E133200 T1 ATE133200 T1 AT E133200T1
Authority
AT
Austria
Prior art keywords
biologically active
active protein
modified
consisting essentially
chemical linkage
Prior art date
Application number
AT90112690T
Other languages
English (en)
Inventor
Yutaka Mizushima
Original Assignee
Yutaka Mizushima
Asahi Glass Co Ltd
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1310056A external-priority patent/JP2679852B2/ja
Application filed by Yutaka Mizushima, Asahi Glass Co Ltd, Seikagaku Kogyo Co Ltd filed Critical Yutaka Mizushima
Application granted granted Critical
Publication of ATE133200T1 publication Critical patent/ATE133200T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
    • C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
    • C12Y115/01001—Superoxide dismutase (1.15.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT90112690T 1989-07-06 1990-07-03 Modifiziertes, biologisch aktives protein ATE133200T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17437189 1989-07-06
JP1310056A JP2679852B2 (ja) 1989-11-29 1989-11-29 経口及び局所投与用生物活性蛋白組成物

Publications (1)

Publication Number Publication Date
ATE133200T1 true ATE133200T1 (de) 1996-02-15

Family

ID=26496004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90112690T ATE133200T1 (de) 1989-07-06 1990-07-03 Modifiziertes, biologisch aktives protein

Country Status (8)

Country Link
US (3) US5109118A (de)
EP (1) EP0406804B1 (de)
AT (1) ATE133200T1 (de)
AU (1) AU647027B2 (de)
CA (1) CA2020439C (de)
DE (1) DE69024862T2 (de)
DK (1) DK0406804T3 (de)
ES (1) ES2084621T3 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869534A (en) * 1992-05-21 1999-02-09 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
CN1132586C (zh) 1993-09-09 2003-12-31 罗拉斯医疗公司 来自胆汁的免疫调节组合物、其制备方法及其用途
JPH08208511A (ja) * 1995-01-31 1996-08-13 Samu Kenkyusho:Kk 抗運動ニューロン疾患剤
BR9607967A (pt) 1995-03-16 1998-01-13 Imutec Pharma Inc Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo
CN1136007C (zh) * 1995-09-06 2004-01-28 协和发酵工业株式会社 脂质代谢改善剂
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US6800607B2 (en) * 2000-02-29 2004-10-05 Ltt Bio-Pharma Co., Ltd. Modified BDNF
WO2004096843A1 (ja) 2003-04-30 2004-11-11 Shigekazu Nakatsugawa 消化器官吸収性ポリペプチド
KR101183856B1 (ko) * 2004-10-12 2012-09-19 가부시키가이샤 엘티티 바이오파마 레시틴화 수퍼옥사이드 디스뮤타아제 조성물 및 그 제조방법
US8052971B2 (en) * 2005-11-21 2011-11-08 MG Biologics Oral use of specific antibodies for intestinal health
KR100752990B1 (ko) * 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
CA2739936C (en) 2008-10-17 2017-12-12 Pharmacofore, Inc. Pharmaceutical compositions with attenuated release of phenolic opioids
JP2013503862A (ja) 2009-09-08 2013-02-04 シグネーチャー セラピューティクス,インク. 酵素切断可能なケトン修飾オピオイドプロドラッグとその任意選択のインヒビターとを含んでなる組成物
US20110262355A1 (en) 2010-04-21 2011-10-27 Jenkins Thomas E Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
US9238020B2 (en) 2010-04-21 2016-01-19 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
AU2012205733B2 (en) 2011-01-11 2015-10-08 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable oxycodone prodrug
EP2683394B1 (de) 2011-03-09 2021-01-06 Signature Therapeutics, Inc. Wirkstoff-prodrugs mit heterocyclischen linkern
WO2012122420A2 (en) 2011-03-09 2012-09-13 Pharmacofore, Inc. Opioid prodrugs with heterocyclic linkers
CN117715632A (zh) 2021-03-09 2024-03-15 恩赛斯生物科学股份有限公司 包含酶可裂解的前药和萘莫司他的组合物及其使用方法
KR20230174213A (ko) 2021-03-09 2023-12-27 엔사이스 바이오사이언시즈 인크. 나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3476770D1 (en) * 1983-04-11 1989-03-23 Meito Sangyo Kk Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique
US4560599A (en) * 1984-02-13 1985-12-24 Marquette University Assembling multilayers of polymerizable surfactant on a surface of a solid material
US4957740A (en) * 1984-10-31 1990-09-18 Centerchem, Inc. Composition for preventing or alleviating skin irritation by formulations containing superoxide dismutase
WO1986004232A1 (en) * 1985-01-18 1986-07-31 Cooper-Lipotech, Inc. Liposome composition and method
JPS63135395A (ja) * 1986-11-28 1988-06-07 Nippon Oil & Fats Co Ltd リン脂質誘導体及びその製造方法
JPS63253031A (ja) * 1987-04-09 1988-10-20 Yutaka Mizushima ス−パ−オキサイドジスムタ−ゼ結合リピツドマイクロスフエア−および該リピツドマイクロスフエア−を含有する脂肪乳剤
IE64284B1 (en) * 1987-08-03 1995-07-26 Ddi Pharmaceuticals Conjugates of superoxide dismutase
US5080833A (en) * 1987-09-21 1992-01-14 Kabushiki Kaisha Toshiba Immobilization of bioactive substance on lipid composition containing modified lipid compound
WO1990011079A1 (en) * 1989-03-29 1990-10-04 Alcon Laboratories, Inc. Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
DE3919982A1 (de) * 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform

Also Published As

Publication number Publication date
EP0406804A3 (en) 1992-04-01
US5109118A (en) 1992-04-28
AU647027B2 (en) 1994-03-17
DK0406804T3 (da) 1996-06-10
CA2020439A1 (en) 1991-01-07
EP0406804B1 (de) 1996-01-17
DE69024862T2 (de) 1996-09-05
AU5865290A (en) 1991-01-10
DE69024862D1 (de) 1996-02-29
EP0406804A2 (de) 1991-01-09
US5362491A (en) 1994-11-08
US5310958A (en) 1994-05-10
CA2020439C (en) 1998-11-24
ES2084621T3 (es) 1996-05-16

Similar Documents

Publication Publication Date Title
DE69024862D1 (de) Modifiziertes, biologisch aktives Protein
FI864457A7 (fi) Kirurgiska biokompositmaterial.
DE3768589D1 (de) Zusammengestelltes leichtgewichtmaterial.
ATE46080T1 (de) Pharmazeutische komposition.
DE3850719D1 (de) Direkt angetriebenes Servoventil.
NO874329D0 (no) Hylser for "sommerfugl"-naaler.
DE3884791D1 (de) Begasungs-Brutschrank.
FI91160B (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
DE3382837T2 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
ES2043609T3 (es) Composiciones de interleucina-2.
DE3784337D1 (de) Fussprothese.
DE3876997D1 (de) Konjugate von superoxiddismutase.
IT1212143B (it) Composizione ad attivita'tricogena.
FI864552A0 (fi) Human-lysozym.
NO890138D0 (no) Porfyrin-insekticider.
PT90504A (pt) Processo para a preparacao de alcoois peptidicos com actividade anticoagulante
FI895844A0 (fi) Koagulation foerhindrande peptider.
DK191089A (da) Biologisk aktive forbindelser
FI900794A0 (fi) Anordning foer att avlaegsna avbrutna tunnband i en bal's bandning.
ATE30966T1 (de) Lagerstabiles universalkontrollserum.
DE3782199D1 (de) Biologisch aktive peptide tan-866.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
DE3771379D1 (de) Optisch aktive hydantoine.
EP0331743A4 (de) Von einem lebenden körper abgeleitetes protein.
BG45041A3 (bg) Хербициден състав

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee